SHBG and Testosterone: Why Sex Hormone Binding Globulin Matters More Than Total T

What is SHBG and why does it matter?

SHBG and testosterone are inseparable on a lab report. Sex hormone binding globulin (SHBG) is a glycoprotein produced primarily by the liver that binds tightly to testosterone, dihydrotestosterone (DHT), and estradiol in the bloodstream. Once bound, those hormones are not biologically available to tissues — they cannot enter cells or activate androgen receptors. Free testosterone, the small unbound fraction, is what your body actually uses.

That single fact reshapes how you should read a testosterone lab. Two men with identical total testosterone of 700 ng/dL can experience completely different symptoms, completely different responses to TRT, and completely different free testosterone numbers — driven almost entirely by SHBG. A man with SHBG of 15 nmol/L will have substantially more free testosterone available to tissues than a man with SHBG of 70 nmol/L at the same total T.

The Endocrine Society's 2018 clinical practice guideline on testosterone therapy in men with hypogonadism (Bhasin et al., Journal of Clinical Endocrinology & Metabolism, PMID 29562364) explicitly recommends measuring free testosterone — calculated or by equilibrium dialysis — when total testosterone is borderline or when SHBG is likely to be abnormal. The American Urological Association's 2018 testosterone deficiency guideline (Mulhall et al., updated 2024) makes the same recommendation. Yet the most common pattern in primary care is to draw a total testosterone, glance at the lab's reference range, and treat or dismiss the patient based on that number alone.

This article walks through what SHBG actually does, how it changes free testosterone, what high and low values mean, why the same TRT dose lands differently in a high-SHBG patient versus a low-SHBG patient, and what the published cohort and trial data say. For context on the broader lab panel, see our TRT blood work schedule. For the related side-effect markers, see estradiol on TRT and hematocrit on TRT.

How SHBG controls free testosterone

Most circulating testosterone in adult men is bound. A widely cited summary from the work of Dunn, Nisula, and Rodbard (Journal of Clinical Endocrinology & Metabolism, 1981, PMID 7195404) — still referenced in modern Endocrine Society guidance — describes the typical distribution as roughly 44 to 65 percent bound to SHBG with high affinity, 30 to 50 percent bound to albumin with much lower affinity, and only about 1 to 4 percent fully unbound. The unbound fraction is what is meant by "free testosterone."

The clinically useful concept is "bioavailable testosterone," which is the sum of free testosterone plus the loosely albumin-bound fraction. Because albumin binding is weak, that fraction can dissociate at the capillary level and reach tissues. SHBG-bound testosterone, in contrast, is essentially locked away — at any given instant the SHBG complex does not deliver hormone to androgen receptors.

The practical consequence is that SHBG functions as a regulator that decides how much of the testosterone you make (or take) is actually available for use:

• High SHBG → more testosterone bound, less free, often hypogonadal symptoms even at "normal" total T
• Low SHBG → more testosterone free, sometimes androgenic symptoms or supraphysiological-feeling responses at modest total T
• Mid-range SHBG → total T tracks reasonably well with how a man feels; total T alone is more interpretable

This is why a single "normal" total testosterone of 450 ng/dL in a man with SHBG of 80 nmol/L can pair with classic low-T symptoms (low libido, fatigue, depressed mood, low morning erections) — calculated free testosterone in that combination is often well below the typical reference floor. The reverse is also true: a total T of 380 ng/dL in a man with SHBG of 12 nmol/L can come with adequate free T and minimal hypogonadal symptoms.

What is a normal SHBG range?

Most reference labs report a normal adult male SHBG range of roughly 10 to 57 nmol/L, though specific cutoffs vary by lab and assay. The widely-used Quest Diagnostics adult male reference is approximately 10 to 50 nmol/L; LabCorp's general male range sits in a similar zone. SHBG is age-dependent — Travison et al. (Journal of Clinical Endocrinology & Metabolism, 2007, PMID 17284627) and subsequent population data show SHBG rises gradually with age while total testosterone falls, which is part of why free testosterone declines with age more steeply than total T.

Common reference points (lab values vary)

Numbers above are general orientation reference points, not lab-specific or guideline-defined targets. Your prescriber interprets your value in context with total T, free T, and symptoms.

Where most TRT patients cluster on SHBG

The chart below illustrates the typical distribution of SHBG values seen in adult men, based on population reference ranges and TRT clinic experience. It is a visual aid for orientation, not patient data.

What causes high SHBG?

High SHBG is the more clinically confusing pattern because it produces low free testosterone in men whose total T looks fine. The Endocrine Society 2018 guideline lists several recognized contributors:

• Aging. SHBG rises modestly with age — Travison et al. 2007 (PMID 17284627) documented this in the Massachusetts Male Aging Study cohort, and similar findings appear in the European Male Aging Study (Wu et al., NEJM 2010, PMID 20554979).
• Hyperthyroidism. Elevated thyroid hormone increases hepatic SHBG synthesis. SHBG can be a useful screening signal for unrecognized thyroid excess.
• Liver disease. Cirrhosis, chronic hepatitis (especially hepatitis C), and some other hepatic conditions raise SHBG.
• Low body fat or low caloric intake. Lean men, endurance athletes, men in calorie deficits, and men with eating disorders frequently run high SHBG.
• Anti-seizure medications. Phenytoin and some other anticonvulsants are well-documented SHBG inducers.
• HIV and chronic illness. Chronic inflammatory states can raise SHBG.
• Genetic variation. SHBG gene polymorphisms account for a meaningful fraction of inter-individual variability — a man whose father had high SHBG often runs high SHBG.

The clinical pattern is a man, often in his 40s or older, who reads as "normal" on a routine total testosterone but presents with classic low-T symptoms. When SHBG is added, it sits at 70 or 90 nmol/L and calculated free T drops below the typical reference floor. This is one of the most common sources of missed diagnoses in primary care, and one of the reasons the Endocrine Society and AUA guidelines specifically call out free T measurement.

What causes low SHBG?

Low SHBG is the metabolic-syndrome pattern. It is most strongly associated with insulin resistance and the cluster of conditions surrounding it. Wallace et al. (Diabetes, 2013, PMID 23193177) and Ding et al. (JAMA, 2006, PMID 16868298) both demonstrated that low SHBG independently predicts incident type 2 diabetes — the relationship is not just a marker of obesity, it appears to carry independent signal.

Common drivers of low SHBG include:

• Insulin resistance and type 2 diabetes. Hyperinsulinemia suppresses hepatic SHBG production.
• Obesity, especially visceral adiposity. Closely tied to insulin resistance, but appears to contribute independently.
• Non-alcoholic fatty liver disease (NAFLD). Hepatic steatosis suppresses SHBG output.
• Hypothyroidism. The mirror image of hyperthyroidism's SHBG effect.
• Cushing syndrome and exogenous glucocorticoids. Steroids lower SHBG.
• Exogenous androgens. TRT, anabolic steroids, and oral 17-alpha-alkylated androgens all suppress SHBG, sometimes dramatically with the latter.
• Acromegaly and high IGF-1 states. Suppress SHBG via insulin-like effects.

The diagnostic challenge with low SHBG is opposite to high SHBG: total testosterone may understate how much testosterone is actually doing work in the body. A total T of 380 ng/dL in a man with SHBG of 12 nmol/L can pair with calculated free T well above the reference floor. Such a patient may not feel hypogonadal even though his total T looks low. Conversely, a low-SHBG patient who starts TRT and reaches a total T of 900 ng/dL can feel supraphysiological at a number that would be tame in a higher-SHBG peer.

How free testosterone is calculated from SHBG

Free testosterone can be measured directly via equilibrium dialysis (the Endocrine Society reference standard) or calculated from total testosterone, SHBG, and albumin using a published formula. The most commonly used equation is the Vermeulen formula (Vermeulen, Verdonck, and Kaufman, Journal of Clinical Endocrinology & Metabolism, 1999, PMID 10523012), which has held up well against equilibrium dialysis in validation studies.

Inputs to the Vermeulen calculation are simple:

1. Total testosterone (ng/dL or nmol/L)
2. SHBG (nmol/L)
3. Albumin (g/dL or g/L) — defaults to 4.3 g/dL if not measured

The output is calculated free testosterone in either ng/dL or pmol/L. The free androgen index (FAI), a different and older metric, is not interchangeable with calculated free T and is not recommended by current guidelines for adult men because of its calibration issues. If your lab report includes "free androgen index," ask whether the lab can run a calculated free T using the Vermeulen formula or perform equilibrium dialysis.

Direct (analog) immunoassay free testosterone is a different test entirely and is generally not recommended in adult men because of inaccuracy at male ranges. The 2018 Endocrine Society guideline specifically calls this out. When "free testosterone" appears on a lab report, check the methodology: equilibrium dialysis is the gold standard, calculated free T (Vermeulen) is acceptable, and direct/analog immunoassay is not. This same kind of methodology distinction matters with estradiol — see estradiol on TRT for the parallel discussion of why the sensitive (LC-MS/MS) E2 assay matters in men.

Why SHBG changes your TRT protocol

Two patients with identical starting total testosterone, identical body weight, and identical TRT prescription often respond very differently. SHBG is one of the biggest hidden variables. Here is how it shapes the way a protocol lands:

1. Same dose, different free T

A 100 mg/week testosterone cypionate protocol that produces a trough total T of 700 ng/dL will produce different free T in a high-SHBG vs low-SHBG patient. The high-SHBG patient may still feel under-treated because free T sits at the low end. The low-SHBG patient may feel over-treated because free T runs high.

2. Injection frequency interacts with SHBG

Low-SHBG patients are particularly sensitive to peak-trough swings. Once-weekly injections produce a sharp peak T followed by a long decline. In a low-SHBG patient, that peak free T can cause estrogenic side effects, hematocrit pressure, anxiety, or other peak-driven symptoms. Splitting the same total weekly dose into twice-weekly or every-other-day injections flattens peaks and frequently improves tolerability. Our TRT blood work schedule covers ester pharmacokinetics in more detail.

3. Delivery method matters more

Transdermal gels produce flatter daily curves than weekly injections and can be a reasonable choice for low-SHBG patients sensitive to peaks. Pellets, conversely, can produce sustained supraphysiological levels and are not always the best match for low-SHBG patients — peaks ride higher for longer. High-SHBG patients sometimes do better on injectables that produce a meaningful peak, since the same peak T translates into less aggressive free T because more of it gets bound.

4. The number to chase is symptoms plus free T, not total T

The Endocrine Society and AUA guidelines both emphasize symptom-based dose titration. In SHBG-edge patients especially, total T can mislead in either direction. Free T calculated from a properly drawn total T and SHBG, interpreted alongside symptoms, is the more useful target. Your prescriber sets the actual targets for your case.

What happens to SHBG on TRT?

Exogenous testosterone suppresses hepatic SHBG production. This is consistent across delivery routes — injections, gels, pellets, and oral testosterone undecanoate — though the magnitude varies with dose and resulting peak T. Most men see SHBG drop within the first 8 to 12 weeks of starting TRT, then stabilize at a new lower set point.

Several patterns are worth knowing:

• The drop is dose-dependent. Higher peak testosterone produces larger SHBG suppression. This is one mechanism by which 200 mg/week regimens feel different from 100 mg/week regimens — see 200mg testosterone per week results for context on supraphysiological dosing.
• 17-alpha-alkylated oral androgens crash SHBG hard. This is a separate class from modern oral testosterone undecanoate (Jatenzo, Kyzatrex, Tlando), which acts via the lymphatic absorption route and does not have the same hepatic toxicity profile. Anabolic steroid users who run 17-alpha drugs frequently see SHBG single digits or undetectable.
• SHBG suppression amplifies free T more than the total T number suggests. A man whose SHBG falls from 40 to 20 nmol/L on TRT will see calculated free T rise more than the change in total T alone would predict. This is part of why follow-up labs need to be interpreted with SHBG, not against pre-TRT total T expectations.
• Removing TRT raises SHBG back. Men coming off TRT typically see SHBG rebound over months as endogenous production recovers. See TRT blood work schedule for monitoring during transitions.

Visualizing SHBG drop on TRT

The chart below illustrates how SHBG typically responds to starting testosterone therapy in a representative high-SHBG and low-SHBG patient. Curves are conceptual based on published pharmacokinetics, not patient data.

What the Tin Tin UK Biobank study found

The largest population-level analysis of SHBG and mortality in men comes from the UK Biobank cohort. Tin Tin et al. (BMC Medicine, 2023, PMID 36915102) analyzed roughly 200,000 men with measured SHBG, total testosterone, and free testosterone, with multi-year follow-up for cause-specific mortality. The findings were nuanced and worth understanding before drawing conclusions:

• Both very low and very high SHBG associated with increased all-cause mortality. The relationship was U-shaped rather than linear.
• Low SHBG associated with cardiometabolic mortality patterns consistent with insulin resistance and visceral adiposity — fitting the established pathophysiology.
• High SHBG associated with cancer-specific mortality patterns in some subgroups, though the authors caution about residual confounding from underlying disease that itself raises SHBG.
• Free testosterone showed clearer associations with mortality patterns than total T alone in many subgroups, reinforcing why free T calculated from SHBG is a more useful clinical signal.

UK Biobank is observational, so it cannot prove causation. What it does add to the literature is large-cohort confirmation that SHBG carries prognostic signal beyond just being a binding protein. The cardiovascular-safety context for testosterone therapy itself comes from the TRAVERSE trial — Lincoff et al. (New England Journal of Medicine, 2023, PMID 37326322) randomized 5,246 men with cardiovascular risk factors to testosterone or placebo and found non-inferiority for the primary composite cardiovascular endpoint. TRAVERSE did not specifically interrogate SHBG dynamics as an outcome modifier, which leaves open questions about how starting SHBG predicts response.

Symptoms that point to an SHBG problem

SHBG itself does not produce symptoms — the symptoms are driven by free testosterone, free estradiol, and downstream signaling. Certain symptom patterns, however, often point to SHBG as an underlying contributor when paired with the right lab results.

Pattern A: High SHBG, normal-looking total T, low T symptoms

• Persistent low libido despite a "normal" total testosterone
• Morning erections rare or absent
• Fatigue not explained by sleep, training load, or mood
• Brain fog, low motivation
• Slow recovery from training in a previously high-performing man
• Mood symptoms that do not fit major depression criteria
• Often paired with: lean body type, age >40, possible hyperthyroid history

Pattern B: Low SHBG with metabolic context

• Visceral adiposity, elevated A1C or fasting insulin
• Total T may look low-normal; calculated free T is often adequate
• NAFLD on imaging or elevated liver enzymes without alcohol
• Strong response to weight loss interventions including GLP-1s — see at-home testosterone test kits for retesting context after weight changes
• On TRT, a tendency toward elevated estradiol and rising hematocrit at modest doses — see hematocrit on TRT

Pattern C: SHBG suppression on TRT

• Started TRT; total T looks reasonable; symptoms feel stronger than expected
• SHBG dropped substantially on follow-up labs
• Free T calculated from new SHBG and total T runs higher than the total T number suggests
• Sometimes paired with elevated estradiol because more substrate is available for aromatization

These are patterns that pair lab values and symptoms. None of them, on their own, diagnoses anything. They exist to help you ask better questions of the prescriber who will actually evaluate you.

Can you change SHBG without medication?

SHBG is downstream of liver, thyroid, insulin, body composition, and androgens. There is no SHBG-specific drug used in standard practice and no established reason to chase SHBG as a number itself. The clinical approach is to address the upstream cause when one exists. Some commonly discussed levers, with realistic expectations:

For high SHBG

• Look for hyperthyroidism. A TSH and free T4 with reflex thyroid antibodies is reasonable when SHBG is unexpectedly high.
• Check liver function and screen for hepatitis. A basic hepatic panel and, when indicated, hepatitis serologies can identify treatable causes.
• Eat enough. Chronic caloric restriction, especially with low body fat, reliably elevates SHBG. Increasing intake over weeks to months sometimes lowers it.
• Adjust training volume. Endurance overtraining can contribute. This is patient-by-patient.
• Review medications. If you are on phenytoin or another SHBG-inducing drug, your prescriber may consider alternatives where appropriate.

For low SHBG

• Treat the metabolic context. Weight loss, exercise, improved insulin sensitivity, and addressing NAFLD all tend to raise SHBG over months.
• Check thyroid. Hypothyroidism can suppress SHBG; treating it often normalizes the value.
• Reassess androgen exposure. If anabolic steroids or supraphysiological TRT doses are contributing, your prescriber will evaluate dose appropriateness.
• Address alcohol. Heavy alcohol use can drive both NAFLD and SHBG suppression.

None of these levers shifts SHBG quickly. Expect months, not weeks, for any meaningful change. And if SHBG is genetically high or genetically low — a meaningful fraction of variability — it may not move much regardless of what you do. The goal is not to force SHBG into a target range; it is to make sure free testosterone and symptoms are interpreted correctly given whatever SHBG you have.

Key takeaways

SHBG is the binding protein that decides how much of your total testosterone is biologically active. Reading a TRT lab without SHBG is reading half the page.

1. Total testosterone alone can mislead in either direction. Free T, calculated from total T and SHBG, is the more clinically useful number — backed by Endocrine Society 2018 and AUA 2018/2024 guidelines.
2. High SHBG produces low free T at normal-looking total T. Aging, hyperthyroidism, liver disease, low body fat, and certain medications are common causes.
3. Low SHBG is the metabolic-syndrome pattern. Insulin resistance, obesity, NAFLD, and exogenous androgens are common drivers. Tin Tin UK Biobank 2023 confirmed independent prognostic signal.
4. The Vermeulen calculated free T formula is the practical workhorse. Direct/analog immunoassay free T is not recommended for adult men by current guidelines.
5. SHBG drops on TRT in a dose-dependent manner. Follow-up labs need to be interpreted with the new SHBG, not pre-TRT expectations.
6. Same dose, different patient, different result. SHBG is one of the biggest reasons two men respond differently to identical TRT protocols.
7. There is no SHBG-specific drug. Address the upstream cause when one exists; otherwise, interpret testosterone correctly given the SHBG you have.

For the broader picture of how SHBG fits into a TRT lab panel and follow-up cadence, the next read is the TRT blood work schedule. For the related markers most often misinterpreted on a TRT panel, see estradiol on TRT and hematocrit on TRT. If you are still in the diagnostic stage and weighing testing options, the best at-home testosterone test kits review covers which services include SHBG. For protocol-side context on how delivery method interacts with SHBG sensitivity, compare TRT gel vs injections and TRT pellets vs injections. And for the broader pillar context, see the blood work guide and TRT 101 overview.